Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


10.07.2017

1 Acta Haematol
4 Am J Hematol
1 Ann Hematol
1 Br J Haematol
3 Hematol Oncol Clin North Am
6 Int J Hematol
1 J Clin Oncol
2 J Pediatr Hematol Oncol
5 Leuk Lymphoma
1 Leukemia
1 Oncol Rep
1 PLoS Comput Biol
1 PLoS Genet
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Haematol

  1. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.
    PubMed     Text format    


    Am J Hematol

  2. KLIL-DRORI AJ, Yin H, Azoulay L, Harnois M, et al
    Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response.
    Am J Hematol. 2017 Jul 3. doi: 10.1002/ajh.24838.
    PubMed     Text format    

  3. TEFFERI A, Barbui T
    Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
    Am J Hematol. 2017;92:94-108.
    PubMed     Text format     Abstract available

  4. NAKASONE H, Fuji S, Yakushijin K, Onizuka M, et al
    Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation.
    Am J Hematol. 2017;92:171-178.
    PubMed     Text format     Abstract available

  5. RAGON BK, Kantarjian H, Jabbour E, Ravandi F, et al
    Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias.
    Am J Hematol. 2017;92:7-11.
    PubMed     Text format     Abstract available


    Ann Hematol

  6. VENTURA FERREIRA MS, Crysandt M, Ziegler P, Hummel S, et al
    Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia.
    Ann Hematol. 2017 Jul 3. doi: 10.1007/s00277-017-3049.
    PubMed     Text format     Abstract available


    Br J Haematol

  7. CHEN Y, Pourabdollah M, Chang H
    Acute myeloid leukemia with mutated NPM1 demonstrating multilineage dysplasia and marked thrombocytosis.
    Br J Haematol. 2017 Jul 5. doi: 10.1111/bjh.14741.
    PubMed     Text format    


    Hematol Oncol Clin North Am

  8. GARCIA JS, Stone RM
    The Development of FLT3 Inhibitors in Acute Myeloid Leukemia.
    Hematol Oncol Clin North Am. 2017;31:663-680.
    PubMed     Text format     Abstract available

  9. PATEL AB, O'Hare T, Deininger MW
    Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors.
    Hematol Oncol Clin North Am. 2017;31:589-612.
    PubMed     Text format     Abstract available

  10. RADICH JP, Mauro MJ
    Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia.
    Hematol Oncol Clin North Am. 2017;31:577-587.
    PubMed     Text format     Abstract available


    Int J Hematol

  11. MATSUO H, Shiga S, Imai T, Kamikubo Y, et al
    Purification of leukemic blast cells from blood smears using laser microdissection.
    Int J Hematol. 2017;106:55-59.
    PubMed     Text format     Abstract available

  12. KARIGANE D, Takubo K
    Metabolic regulation of hematopoietic and leukemic stem/progenitor cells under homeostatic and stress conditions.
    Int J Hematol. 2017;106:18-26.
    PubMed     Text format     Abstract available

  13. KUNIMOTO H, Nakajima H
    Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Int J Hematol. 2017;106:34-44.
    PubMed     Text format     Abstract available

  14. UEMURA S, Tamura A, Saito A, Hasegawa D, et al
    Reemergence of translocation t(11;19)(q23;p13.1) in the absence of clinically overt leukemia.
    Int J Hematol. 2017 Jul 1. doi: 10.1007/s12185-017-2289.
    PubMed     Text format     Abstract available

  15. MIYAZAKI Y
    JSH Guideline for Tumors of Hematopoietic and Lymphoid Tissues: Leukemia: 6. Myelodysplastic syndromes (MDS).
    Int J Hematol. 2017 Jul 4. doi: 10.1007/s12185-017-2272.
    PubMed     Text format    

  16. HIRANO M, Ohno N, Tanosaki R, Mochizuki M, et al
    Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood-ocular barrier.
    Int J Hematol. 2017 Jul 4. doi: 10.1007/s12185-017-2293.
    PubMed     Text format     Abstract available


    J Clin Oncol

  17. HARDY KK, Embry L, Kairalla JA, Helian S, et al
    Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.
    J Clin Oncol. 2017 Jul 3:JCO2016717587. doi: 10.1200/JCO.2016.71.7587.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  18. IQBAL A, Weinstein J, Angelova V, Dighe D, et al
    A Rare Case of Spontaneous Remission of Terminal Deoxynucleotidyl Transferase Negative B-acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jul 3. doi: 10.1097/MPH.0000000000000906.
    PubMed     Text format     Abstract available

  19. SHIGEMURA T, Motobayashi M, Matsuda K, Shimodaira T, et al
    Acute Myeloid Leukemia in a Patient With X-linked Severe Combined Immunodeficiency.
    J Pediatr Hematol Oncol. 2017 Jul 3. doi: 10.1097/MPH.0000000000000892.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  20. XU L, Zhang M, Li H, Guan W, et al
    SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.
    Leuk Lymphoma. 2017 Jul 6:1-13. doi: 10.1080/10428194.2017.1344843.
    PubMed     Text format     Abstract available

  21. HAMPRAS SS, Locke FL, Chavez JC, Patel NS, et al
    Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients.
    Leuk Lymphoma. 2017 Jul 6:1-7. doi: 10.1080/10428194.2017.1342822.
    PubMed     Text format     Abstract available

  22. XU W, Li X, Quan L, Yao J, et al
    Arsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia.
    Leuk Lymphoma. 2017 Jul 6:1-10. doi: 10.1080/10428194.2017.1346253.
    PubMed     Text format     Abstract available

  23. SALMOIRAGHI S, Rambaldi A, Spinelli O
    TP53 in adult acute lymphoblastic leukemia.
    Leuk Lymphoma. 2017 Jul 6:1-12. doi: 10.1080/10428194.2017.1344839.
    PubMed     Text format     Abstract available

  24. CALVELLO C, Rocca B, Klersy C, Zappatore R, et al
    Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia.
    Leuk Lymphoma. 2017 Jul 6:1-8. doi: 10.1080/10428194.2017.1346252.
    PubMed     Text format     Abstract available


    Leukemia

  25. BECK D, Thoms JAI, Palu C, Herold T, et al
    A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.
    Leukemia. 2017 Jul 4. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  26. HAN XJ, Shi SL, Wei YF, Jiang LP, et al
    Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
    Oncol Rep. 2017 Jun 28. doi: 10.3892/or.2017.5765.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  27. KAVEH K, Takahashi Y, Farrar MA, Storme G, et al
    Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance.
    PLoS Comput Biol. 2017;13:e1005482.
    PubMed     Text format     Abstract available


    PLoS Genet

  28. XU B, Li H, Perry JM, Singh VP, et al
    Ribosomal DNA copy number loss and sequence variation in cancer.
    PLoS Genet. 2017;13:e1006771.
    PubMed     Text format     Abstract available


    PLoS One

  29. GU R, Wei H, Wang Y, Lin D, et al
    The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia.
    PLoS One. 2017;12:e0180624.
    PubMed     Text format     Abstract available

  30. WOYWOD C, Gruber FX, Engh RA, Fla T, et al
    Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.
    PLoS One. 2017;12:e0179700.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: